Tolerability and Pharmacokinetics of Toripalimab in Combination With Axitinib in Patients With Kidney Cancer and Melanoma
Clinical trial NCT03086174 · UNKNOWN
Trial details
- NCT number
- NCT03086174
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-31
- Primary completion
- 2019-12-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.